Literature DB >> 16061765

Cortical gamma-aminobutyric acid type A-benzodiazepine receptors in recovery from alcohol dependence: relationship to features of alcohol dependence and cigarette smoking.

Julie K Staley1, Christopher Gottschalk, Ismene L Petrakis, Ralitza Gueorguieva, Stephanie O'Malley, Ronald Baldwin, Peter Jatlow, Nicolaas Paul L G Verhoeff, Edward Perry, David Weinzimmer, Erin Frohlich, Elizabeth Ruff, Christopher H van Dyck, John P Seibyl, Robert B Innis, John H Krystal.   

Abstract

CONTEXT: Adaptations in gamma-aminobutyric acid type A (GABA(A))-benzodiazepine receptors contribute to the neurobiology of human alcohol dependence and withdrawal.
OBJECTIVE: To study GABA(A)-benzodiazepine receptor adaptations in subjects with alcohol dependence over the first month of sobriety.
DESIGN: Inpatients who were not receiving medication, were either smokers or nonsmokers, and had alcohol dependence completed 2 iodine I 123-labeled iomazenil single-photon emission computed tomographic scans: 1 scan at a mean +/- SD of 4.9 +/- 2.5 days of sobriety (n = 23) and 1 scan at a mean +/- SD of 29.8 +/- 7.6 days of sobriety (n = 20). Participants in a matched group of healthy subjects (n = 15) completed 1 single-photon emission computed tomographic scan. PARTICIPANTS: Men with alcohol dependence (n = 27) and a matched healthy comparison group (n = 15). MAIN OUTCOME MEASURES: (123)I-iomazenil single-photon emission computed tomographic images were converted to units of distribution volume (regional activity/free (123)I-iomazenil) and were analyzed using voxel-based statistical parametric mapping and regions of interest analyses. The relationships between (123)I-iomazenil distribution volume, clinical features of alcohol dependence, and smoking status were evaluated.
RESULTS: (123)I-iomazenil uptake was elevated in several cortical regions, with a more prominent increase in nonsmokers with alcohol dependence as compared with smokers with alcohol dependence at 1 week of abstinence from alcohol. No significant differences were observed at 4 weeks of abstinence. At 1 week of abstinence, frontal (123)I-iomazenil uptake correlated with the severity of alcohol withdrawal and the number of days since the last alcoholic drink was consumed. No significant associations were observed for smokers with alcohol dependence.
CONCLUSIONS: These data demonstrate time-dependent regulation of cortical GABA(A)-benzodiazepine receptors associated with the recovery from alcohol dependence. Higher GABA(A)-benzodiazepine receptor levels during acute withdrawal may reflect a compensation for reduced receptor function, which is thought to contribute to alcohol tolerance and withdrawal. The subsequent decline may reflect "normalization" of GABA(A) receptor function with sobriety. Smoking may attenuate GABA(A) receptor adaptations associated with alcohol dependence and may contribute to the comorbidity between alcoholism and smoking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061765     DOI: 10.1001/archpsyc.62.8.877

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  18 in total

Review 1.  Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence.

Authors:  Kelly P Cosgrove; Irina Esterlis; Graeme F Mason; Frederic Bois; Stephanie S O'Malley; John H Krystal
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

2.  Mecamylamine treatment for alcohol dependence: a randomized controlled trial.

Authors:  Ismene L Petrakis; Elizabeth Ralevski; Ralitza Gueorguieva; Stephanie S O'Malley; Albert Arias; Kevin A Sevarino; Jane S Jane; Erin O'Brien; John H Krystal
Journal:  Addiction       Date:  2017-10-12       Impact factor: 6.526

Review 3.  Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.

Authors:  Jing Liang; Richard W Olsen
Journal:  Acta Pharmacol Sin       Date:  2014-08       Impact factor: 6.150

Review 4.  GABAergic contributions to alcohol responsivity during adolescence: insights from preclinical and clinical studies.

Authors:  Marisa M Silveri
Journal:  Pharmacol Ther       Date:  2014-03-11       Impact factor: 12.310

Review 5.  How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal.

Authors:  Ansel T Hillmer; Graeme F Mason; Lisa M Fucito; Stephanie S O'Malley; Kelly P Cosgrove
Journal:  Alcohol Clin Exp Res       Date:  2015-10-28       Impact factor: 3.455

Review 6.  Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity.

Authors:  Scott J Moeller; Edythe D London; Georg Northoff
Journal:  Neurosci Biobehav Rev       Date:  2015-12-01       Impact factor: 8.989

7.  Nicotine and Nicotine Abstinence Do Not Interfere with GABAA Receptor Neuroadaptations During Alcohol Abstinence.

Authors:  Ansel T Hillmer; Tracy Kloczynski; Christine M Sandiego; Brian Pittman; Jon M Anderson; David Labaree; Hong Gao; Yiyun Huang; Giuseppe Deluliis; Stephanie S O'Malley; Richard E Carson; Kelly P Cosgrove
Journal:  Alcohol Clin Exp Res       Date:  2016-03-12       Impact factor: 3.455

Review 8.  The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress.

Authors:  Sandeep Kumar; Patrizia Porcu; David F Werner; Douglas B Matthews; Jaime L Diaz-Granados; Rebecca S Helfand; A Leslie Morrow
Journal:  Psychopharmacology (Berl)       Date:  2009-05-20       Impact factor: 4.530

9.  Time for Cigarette Smoke Exposure Chambers?

Authors:  Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2016-03-14       Impact factor: 3.455

Review 10.  Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system.

Authors:  William M Doyon; Alyse M Thomas; Alexey Ostroumov; Yu Dong; John A Dani
Journal:  Biochem Pharmacol       Date:  2013-07-19       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.